14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.90 $2.79 Thursday, 25th Apr 2024 FGEN stock ended at $1.02. This is 3.63% more than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 13.75% from a day low at $0.90 to a day high of $1.03.
90 days $0.88 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Oct 25, 2023 $0.530 $0.550 $0.490 $0.535 1 460 044
Oct 24, 2023 $0.538 $0.543 $0.507 $0.518 1 232 234
Oct 23, 2023 $0.532 $0.550 $0.500 $0.507 1 865 096
Oct 20, 2023 $0.580 $0.615 $0.542 $0.550 1 050 285
Oct 19, 2023 $0.607 $0.613 $0.560 $0.577 1 469 211
Oct 18, 2023 $0.630 $0.641 $0.585 $0.595 1 335 993
Oct 17, 2023 $0.622 $0.665 $0.597 $0.651 1 351 770
Oct 16, 2023 $0.592 $0.650 $0.580 $0.621 1 003 750
Oct 13, 2023 $0.614 $0.631 $0.590 $0.595 1 230 131
Oct 12, 2023 $0.702 $0.710 $0.617 $0.620 3 197 763
Oct 11, 2023 $0.792 $0.81 $0.690 $0.706 2 907 778
Oct 10, 2023 $0.708 $0.794 $0.701 $0.790 3 897 142
Oct 09, 2023 $0.724 $0.738 $0.700 $0.720 2 929 604
Oct 06, 2023 $0.732 $0.764 $0.662 $0.753 4 446 809
Oct 05, 2023 $0.750 $0.772 $0.714 $0.719 7 987 531
Oct 04, 2023 $0.780 $0.790 $0.692 $0.750 5 270 324
Oct 03, 2023 $0.81 $0.82 $0.737 $0.740 5 726 020
Oct 02, 2023 $0.86 $0.90 $0.81 $0.81 6 079 383
Sep 29, 2023 $0.99 $0.99 $0.84 $0.86 7 230 169
Sep 28, 2023 $0.97 $1.00 $0.90 $0.97 4 620 817
Sep 27, 2023 $0.86 $0.98 $0.86 $0.96 6 533 380
Sep 26, 2023 $0.84 $0.93 $0.83 $0.87 5 244 393
Sep 25, 2023 $0.786 $0.88 $0.763 $0.84 6 466 729
Sep 22, 2023 $0.85 $0.88 $0.771 $0.786 4 532 571
Sep 21, 2023 $0.84 $0.89 $0.81 $0.84 3 245 987
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT